Description

Sorafenib Tablets are an oral targeted therapy used to treat advanced kidney cancer and hepatocellular carcinoma. By inhibiting multiple kinases involved in tumor growth and angiogenesis, Sorafenib slows cancer progression, improves survival rates, and enhances overall treatment outcomes for patients.